When insurers control #PBMs, pharmacies, and even the providers who write prescriptions, they steer patients and dollars to their own pockets. We appreciate @SenWarren taking on this important issue. https://t.co/OMRAr1BSED #InsuranceConsolidation#HealthCareCompetition
Recently passed #PBMreform legislation is a crucial step to correct the broken incentives in our prescription drug system and improve drug affordability.
We hope @POTUS keeps up the pressure on the large insurance companies and their PBMs.
Behind rising healthcare costs are powerful industry forces that shift costs onto patients. New England families deserve better transparency, competition, and oversight. Our health can’t wait. @VoteJulieMiles https://t.co/11XFfOaF8N
Insurance costs have outpaced wage growth by a wide margin, leaving many New England families and #patients vulnerable. Big-insurance is becoming a big problem. https://t.co/qUs6pHhoJM
NEW: Insurance giants are hiding billions meant to lower Americans’ drug costs.
Our year-long investigation details how CVS, UnitedHealth, and Cigna created shell companies to evade reform efforts and hide payments received from drugmakers.
Cc: @mcuban
A new bipartisan bill in Congress, led by @SenatorHassan@SenWhitehouse & @SenPeterWelch would implement reforms to PBMs that increase transparency, curb harmful practices and bring meaningful relief to families across New England. Read the op-ed below. https://t.co/kgqCvFgnaD
“For the hemophilia community, consistent and affordable access to specialized medication is not optional — it is essential for survival.”
In an op-ed in @NHBR, NEHA's ED, Rich Pezzillo, highlights how #PBMs drive up costs and limit access to lifesaving treatments for patients.
The new Crapo/Wyden #PBM reform bill is a smart, bipartisan solution to help patients. We want to thank @SenatorHassan@SenWhitehouse@SenPeterWelch for their leadership and encourage the rest of the New England Senate delegation support this bill. https://t.co/j4PrjSWJyP
The #340BAccessAct helps restore the program’s original intent: making sure discounts benefit the communities and patients who need them most.
What do NH leaders, patient advocates, and national experts have to say? @RepGoodlander@RepChrisPappas. https://t.co/mBGRFu2hcx
PBMs are part of the problem and take 50% of every dollar spent on medicines and, #MFN is not the solution b/c importing foreign prices means less treatments and cures for New England patients. @SenatorHassan@SenatorShaheen https://t.co/dF5HkgPHTM
PBMs are part of the problem and take 50% of every dollar spent on medicines and, #MFN is not the solution b/c importing foreign prices means less treatments and cures for New England patients. @SenatorHassan@SenatorShaheen https://t.co/dF5HkgPa4e
This month, we recognize the strength of those living with bleeding disorders. Early diagnosis, access to treatment, and research advancements are key to improving lives. Join us in spreading awareness! @NewEnglandHemo@nbd_foundation#BleedingDisordersAwarenessMonth
The EO issued by @POTUS to eliminate the #PillPenalty represents an important step toward preserving access to, and encouraging the discovery and development of new, undiscovered treatments. Our community has always believed that #InnovationMatters! https://t.co/eWFXFMMB4q
Thank you for meeting with us, @Rep_Magaziner!
We’re looking forward to partnering with you to protect Medicaid and the patients and families who rely on it every day for the care and treatment they need.
Great meeting with the National Bleeding Disorders Foundation to talk about protecting access to life-saving care.
Every Rhode Islander deserves the treatment they need, and I’m working to make sure those with bleeding disorders aren’t left behind.